I recently joined the Price lab in June 2015 after completing my PhD in Experimental and Molecular Medicine at the Geisel School of Medicine at Dartmouth. I am interested in the development of biomarkers for prenatal adversity through a systems biology approach. My thesis research involved the influence of the placental epigenome and its contribution to newborn neurobehavior. I applied candidate and genome wide approaches to identify epigenetic variation associated with neurobehavioral outcomes in newborns, which may someday be used as novel molecular diagnostic tools to identify at risk infants, or translated into targets for therapeutic intervention. In my postdoctoral work, I will be expanding my data analysis techniques and working with collaborators to identify molecular biomarkers that may predict preterm birth and adverse neonatal outcomes such as preeclampsia. For more information about this research, please click here.
For a complete list of my publications, you can visit my page on PubMed.